Main Article Content
Objective: To compare the anti-hyperglycemic and anti-dyslipidemia effects of insulin verses metformin in diabetic
Material and Methods: Total of 240 blood samples were collected (120 from male and female) for all the three groups
i.e. Group-I serve as non-diabetic individuals, Group-II included diabetic patients treated with insulin and Group-III
included diabetic patients treated with metformin. The study period was from January 2018 to September 2018. Fasting-
serum-glucose, lipid profile, triglyceride, AST and ALT analysis were done with serum samples. Body mass index
was also measured for each subject.
Results: A significant weight gain was recorded in metformin treated group than insulin treated group. Insulin showed
more significant anti-hyperglycemic effects than metformin treated group. Insulin therapy showed more significant reduction
for total-cholesterol and very low density-lipoprotein both in male and female groups. For low-density-lipoprotein a
significant reduction and for high-density-lipoprotein a significant increase was found only in male insulin treated group.
Insulin also showed significant increase for alanine aminotransferase, aspartate aminotransferase only in male group.
Conclusion: Insulin showed stronger anti-hyperglycemic, anti-hypercholesterolemia activities than metformin. Insulin
showed more significant improvement in lipid profile.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
CopyRight . © 2008-2020 Khyber Medical College Peshawar | All Rights Reserved